22.11.23|Meir OrbachThe Israeli firm, which develops a biocompatible, coral-based, off-the-shelf implant for damaged joints, will initially receive $180 million in cash and up to a further $150 million contingent on financial performance
30.08.21|Golan HazaniThe American orthobiologics company announced that it has activated its option to purchase the Kfar Saba-based company by transferring an initial $50 million
26.02.20|Golan HazaniThe company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
More stories in CTech
